Skip to content

Clinical trials

Phase 3 Drug-Related Side Effects and Adverse Reactions trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Drug-Related Side Effects and Adverse Reactions Phase: Phase 3 Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20033
20041
20051
20062
20101
20191
20223
20234
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated3
Recruiting2
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology2
Radiation Therapy Oncology Group2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Alexandria University1
Case Comprehensive Cancer Center1
Centre de Recherche Médicale de Lambaréné1
Consorcio Centro de Investigación Biomédica en Red (CIBER)1
Dana-Farber Cancer Institute1
European Organisation for Research and Treatment of Cancer - EORTC1
Gynecologic Oncology Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Drug-Related Side Effects and Adverse Reactions24
Breast Neoplasms6
Leukemia3
Anemia2
Breast Neoplasms, Male2
Colorectal Neoplasms2
Lung Neoplasms2
Radiation Injuries2
Rectal Neoplasms2
Acute Kidney Injury1

Trials

Showing 76 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.